Alpine Immune Sciences (ALPN) Short Interest Ratio & Short Volume → Buy this small stock before coming AI Tidal Wave (From Chaikin Analytics) (Ad) Free ALPN Stock Alerts $64.97 +0.01 (+0.02%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alpine Immune Sciences Short Interest DataCurrent Short Volume3,890,000 sharesPrevious Short Volume4,740,000 sharesChange Vs. Previous Month-17.93%Dollar Volume Sold Short$251.26 millionShort Interest Ratio / Days to Cover1.7Last Record DateApril 30, 2024Outstanding Shares68,600,000 sharesPercentage of Shares Shorted5.67%Today's Trading Volume4,288,333 sharesAverage Trading Volume1,875,865 sharesToday's Volume Vs. Average229% Short Selling Alpine Immune Sciences ? Sign up to receive the latest short interest report for Alpine Immune Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALPN Short Interest Over TimeALPN Days to Cover Over TimeALPN Percentage of Float Shorted Over Time Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. Alpine Immune Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,890,000 shares $251.26 million -17.9%N/A1.7 $64.59 4/15/20244,740,000 shares $305.35 million -10.2%N/A2.1 $64.42 3/31/20245,280,000 shares $209.30 million -5.9%N/A4.4 $39.64 3/15/20245,610,000 shares $204.09 million +26.6%N/A5.1 $36.38 2/29/20244,430,000 shares $156.02 million +9.9%N/A4.4 $35.22 2/15/20244,030,000 shares $120.42 million +20.7%N/A4.3 $29.88 Get the Latest News and Ratings for ALPN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alpine Immune Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,340,000 shares $88.88 million +38.6%N/A3.6 $26.61 1/15/20242,410,000 shares $49.28 million -39.5%N/A3.1 $20.45 12/31/20233,980,000 shares $75.86 million +32.7%N/A5 $19.06 12/15/20233,000,000 shares $56.70 million -9.6%N/A4 $18.90 11/30/20233,320,000 shares $51.46 million -23.7%N/A5.1 $15.50 11/15/20234,350,000 shares $54.94 million +51.0%N/A7.5 $12.63 10/31/20232,880,000 shares $29.49 million +31.5%N/A5.6 $10.24 10/15/20232,190,000 shares $22.47 million -21.8%N/A6.8 $10.26 9/30/20232,800,000 shares $32.06 million +6.9%N/A11 $11.45 9/15/20232,620,000 shares $32.93 million +4.0%N/A11.3 $12.57 8/31/20232,520,000 shares $31.12 million +28.6%N/A10.8 $12.35 8/15/20231,960,000 shares $26.46 million +31.5%N/A8.9 $13.50 7/31/20231,490,000 shares $18.68 million +0.7%N/A6.5 $12.54 7/15/20231,480,000 shares $16.32 million -3.3%N/A7.8 $11.03 6/30/20231,530,000 shares $15.73 million +26.5%N/A8.9 $10.28 6/15/20231,210,000 shares $13.19 million +1.7%N/A7.2 $10.90 5/31/20231,190,000 shares $11.85 million +3.5%N/A10.3 $9.96 5/15/20231,150,000 shares $9.97 million +8.5%N/A10.7 $8.67 4/30/20231,060,000 shares $7.94 million +1.9%N/A14.8 $7.49 4/15/20231,040,000 shares $7.60 million -1.0%N/A13.3 $7.31 3/31/20231,050,000 shares $8.11 million +17.6%N/A12.5 $7.72 3/15/2023892,900 shares $7.18 million +10.8%N/A9.7 $8.04 2/28/2023805,900 shares $6.42 million +8.7%N/A7.5 $7.97 2/15/2023741,100 shares $6.24 million -2.8%N/A6.7 $8.42 1/31/2023762,700 shares $6.41 million -6.6%N/A6.7 $8.40 1/15/2023816,200 shares $7.14 million -65.0%N/A6.6 $8.75 12/30/20222,330,000 shares $17.13 million -0.4%N/A19 $7.35 12/15/20222,340,000 shares $15.28 million +6.4%N/A18.4 $6.53 11/30/20222,200,000 shares $13.82 million +4.3%N/A19.4 $6.28 11/15/20222,110,000 shares $13.19 million +11.6%N/A19.4 $6.25 10/31/20221,890,000 shares $11.17 million +2.7%N/A19.5 $5.91 10/15/20221,840,000 shares $13.06 million +12.9%N/A20.2 $7.10 9/30/20221,630,000 shares $11.74 million +19.0%N/A20.7 $7.20 9/15/20221,370,000 shares $11.10 million -2.1%7.0%17.6 $8.10Buy this small stock before coming AI Tidal Wave (Ad)The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. ALPN Short Interest - Frequently Asked Questions What is Alpine Immune Sciences' current short interest? Short interest is the volume of Alpine Immune Sciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,890,000 shares of ALPN short. Learn More on Alpine Immune Sciences' current short interest. What is a good short interest ratio for Alpine Immune Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALPN shares currently have a short interest ratio of 2.0. Learn More on Alpine Immune Sciences's short interest ratio. Which institutional investors are shorting Alpine Immune Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alpine Immune Sciences: Jane Street Group LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Alpine Immune Sciences' short interest increasing or decreasing? Alpine Immune Sciences saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 3,890,000 shares, a decrease of 17.9% from the previous total of 4,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Alpine Immune Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Alpine Immune Sciences: Madrigal Pharmaceuticals, Inc. (18.67%), Nuvalent, Inc. (20.08%), Alkermes plc (7.62%), Perrigo Company plc (2.54%), Crinetics Pharmaceuticals, Inc. (6.23%), Insmed Incorporated (5.74%), HUTCHMED (China) Limited (0.26%), Apellis Pharmaceuticals, Inc. (10.21%), Axsome Therapeutics, Inc. (16.23%), Prestige Consumer Healthcare Inc. (3.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Alpine Immune Sciences stock? Short selling ALPN is an investing strategy that aims to generate trading profit from Alpine Immune Sciences as its price is falling. ALPN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alpine Immune Sciences? A short squeeze for Alpine Immune Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPN, which in turn drives the price of the stock up even further. How often is Alpine Immune Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: MDGL Short Interest Data NUVL Short Interest Data ALKS Short Interest Data PRGO Short Interest Data CRNX Short Interest Data INSM Short Interest Data HCM Short Interest Data APLS Short Interest Data AXSM Short Interest Data PBH Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALPN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press